Clinical Trial

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated October 14, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study tests whether early heart screening and treatment for iron overload in subjects with sickle cell disease can prevent heart problems and reduce hospitalizations.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-09; most recent amendment 2025-10-09.
Status change: Not Yet Recruiting → Recruiting 2025-10-09
Trial Details
NCT Number NCT07023666
Lead Sponsor Inova Health Care Services
Conditions Sickle Cell Disease
Enrollment 100 participants
Start Date 2025-10-07
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-14